Dr. Jonathan Weiss holds a Diploma in Molecular Biology and a PhD in Molecular Medicine from the University of Cologne, where he worked on deciphering oncogenic dependencies in Non-Small Cell Lung (NSCL) tumors. He then held a postdoc position in Melbourne, Australia, where he started working with digital PCR. He returned to the University Hospital Cologne in 2015 as an independent translational research group leader, where he developed and established digital PCR assays to answer complex clinical questions. He joined QIAGEN in 2023 as an R&D Scientist and he is currently heading the digital PCR Feasibility Group, focusing on new approaches and research to push the limits of digital PCR.

Jan Rohde received his MSc in Pharmaceutical and Medical Drug Innovation from the University of Groningen, the Netherlands and his PhD from Medical University Frankfurt, Germany where he worked on developing microRNA therapeutics. He went on to hold several scientific roles in multinational companies, such as Thermo Fisher Scientific and Takara Bio Europe. Jan joined QIAGEN in 2020 as a sales application specialist for digital PCR. He is currently heading the QIAcuity digital PCR field support team in the European region, with a focus on training QIAcuity users to use their instrument to full capabilities.